Characterizing vaccine responses using host genomic and transcriptomic analysis

Clinical Infectious Diseases

Volumn 57, Issue 6, 2013, Pages 860-869

  O'Connor, Daniel ^a   Pollard, Andrew J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

genomics; heritability; immunogenetics; transcriptomics; vaccine immunology

Indexed keywords

ANTIBODY; B CELL ACTIVATING FACTOR; BCG VACCINE; DIPHTHERIA VACCINE; GAMMA INTERFERON; HEAT SHOCK PROTEIN; HEMAGGLUTININ; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; HLA DPB1 ANTIGEN; INACTIVATED VACCINE; INFLUENZA VACCINE; INTERLEUKIN 13; INTRINSIC FACTOR; LIVE VACCINE; MEASLES MUMPS RUBELLA VACCINE; MIFAMURTIDE; ORAL POLIOMYELITIS VACCINE; PERTACTIN; PERTUSSIS TOXIN; PNEUMOCOCCUS VACCINE; TETANUS TOXOID; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TRANSCRIPTOME; TUBERCULIN; VACCINE;

ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; CELL DIFFERENTIATION; CELLULAR IMMUNITY; CLINICAL TRIAL (TOPIC); COMPARATIVE STUDY; DIPHTHERIA; DIZYGOTIC TWINS; DNA SEQUENCE; ENVIRONMENTAL FACTOR; GENE LOCUS; GENETIC VARIABILITY; GENOME; HAEMOPHILUS INFLUENZAE; HEPATITIS A VIRUS; HEPATITIS B; HEPATITIS B VIRUS; HERITABILITY; HLA SYSTEM; HOST CELL; HUMAN; IMMUNE RESPONSE; INFECTION; INNATE IMMUNITY; MONOZYGOTIC TWINS; POLIOMYELITIS; PRIORITY JOURNAL; RECEPTOR UPREGULATION; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; TETANUS; TRANSCRIPTOMICS;

GENOMICS; HERITABILITY; IMMUNOGENETICS; TRANSCRIPTOMICS; VACCINE IMMUNOLOGY;

GENE EXPRESSION PROFILING; GENOME-WIDE ASSOCIATION STUDY; GENOMICS; HUMANS; IMMUNOGENETIC PHENOMENA; VACCINES;

EID: 84883234966     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cit373     Document Type: Review

References (40)

1. World Health Organization. State of the world's vaccines and immunization. Available at http://whqlibdoc.who.int/publications/2009/ 9789241563864-eng.pdf. Accessed 1 December 2012.
2. Roome AJ, Walsh SJ, Cartter ML, Hadler JL. Hepatitis B vaccine responsiveness in Connecticut public safety personnel. JAMA. 1993; 270: 2931-4.
3. Perrett K, Winter A, Kibwana E, et al. Antibody persistence after serogroup C meningococcal conjugate immunization of United kingdom primary-school children in 1999-2000 and response to a booster: a phase 4 clinical trial. Clin Infect Dis. 2010; 50:1601-10.
4. Van Loveren H, Van Amsterdam J, Vandebriel R, et al. Vaccineinduced antibody responses as parameters of the influence of endogenous and environmental factors. Environ Health Perspect. 2001; 109: 757-64.
5. Höhler T, Reuss E, Evers N, et al. Differential genetic determination of immune responsiveness to hepatitis B surface antigen and to hepatitis Avirus: a vaccination study in twins. Lancet. 2002; 360:991-5.
6. Newport M, Goetghebuer T,Weiss H, et al. Genetic regulation of immune responses to vaccines in early life. Genes Immun. 2004; 5:122-9.
7. Lee Y, Newport M, Goetghebuer T, et al. Influence of genetic and environmental factors on the immunogenicity of Hib vaccine in Gambian twins. Vaccine. 2006; 24:5335-40.
8. Konradsen H, Henrichsen J, Wachmann H, Holm N. The influence of genetic factors on the immune response as judged by pneumococcal vaccination of mono-and dizygotic Caucasian twins. Clin Exp Immunol. 1993; 92:532-6.
9. Png E, Thalamuthu A, Ong RT, Snippe H, Boland GJ, Seielstad M. A genome-wide association study of hepatitis B vaccine response in an Indonesian population reveals multiple independent risk variants in the HLA region. Hum Mol Genet. 2011; 20: 3893-8.
10. Kamatani Y, Wattanapokayakit S, Ochi H, et al. A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians. Nat Genet. 2009; 41:591-5.
11. Ovsyannikova IG, Kennedy RB, O'Byrne M, Jacobson RM, Pankratz VSPoland GA. Genome-wide association study of antibody response to smallpox vaccine. Vaccine. 2012; 30:4182-9.
12. Pajewski NM, Parker SD, Poland GA, et al. The role of HLA-DR-DQ haplotypes in variable antibody responses to Anthrax Vaccine Adsorbed. Genes Immun. 2011; 12:457-65.
13. Ovsyannikova I, Jacobson R, Vierkant R, O'Byrne M, Poland G. Replication of rubella vaccine population genetic studies: Validation of HLA genotype and humoral response associations. Vaccine. 2009; 27: 6926-6931.
14. Ovsyannikova IG, Pankratz VS, Vierkant RA, Jacobson RM, Poland GA. Consistency of HLA associations between two independent measles vaccine cohorts: a replication study. Vaccine. 2012; 30:2146-52.
15. Dhiman N, Ovsyannikova I, Vierkant R, et al. Associations between SNPs in toll-like receptors and related intracellular signaling molecules and immune responses to measles vaccine: preliminary results. Vaccine. 2008; 26:1731-6.
16. Moore CE, Hennig BJ, Perrett KP, et al. SNPs in the TLR3 and CD44 genes are associated with persistence of vaccine-induced immunity to serogroup C meningococcal conjugate vaccine. Clin Vaccine Immunol. 2011; 19:295-303.
17. Kimman T, Banus S, Reijmerink N, et al. Association of interacting genes in the toll-like receptor signaling pathway and the antibody response to pertussis vaccination. PLoS ONE. 2008; 3:e3665.
18. Ladhani SN, Davila S, Hibberd ML, et al. Association between singlenucleotide polymorphisms in Mal/TIRAP and interleukin-10 genes and susceptibility to invasive haemophilus influenzae serotype b infection in immunized children. Clin Infect Dis. 2010; 51:761-7.
19. Yucesoy B, Johnson V, Fluharty K, et al. Influence of cytokine gene variations on immunization to childhood vaccines. Vaccine. 2009; 27: 6991-7.
20. Höhler T, Reuss E, Freitag C, Schneider P. A functional polymorphism in the IL-10 promoter influences the response after vaccination with HBsAg and hepatitis A. Hepatology. 2005; 42:72-6.
21. Pan L, ZhangW, Liang Z, et al. Association between polymorphisms of the cytokine and cytokine receptor genes and immune response to hepatitis B vaccination in a Chinese Han population. J Med Virol. 2012; 84:26-33.
22. Reif D, McKinney B, Motsinger A, et al. Genetic basis for adverse events after smallpox vaccination. J Infect Dis. 2008; 198:16-22.
23. O'Brien TR, Kohaar I, Pfeiffer RM, et al. Risk alleles for chronic hepatitis B are associated with decreased mRNA expression of HLA-DPA1 and HLA-DPB1 in normal human liver. Genes Immun. 2011; 12: 428-33.
24. Valkov E, Stamp A, Dimaio F, et al. Crystal structure of Toll-like receptor adaptor MAL/TIRAP reveals the molecular basis for signal transduction and disease protection. Proc Natl Acad Sci USA. 2011; 108: 14879-84.
25. Skol AD, Scott LJ, Abecasis GR, Boehnke M. Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. Nat Genet. 2006; 38:209-13.
26. Querec T, Akondy R, Lee E, et al. Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans. Nat Immunol. 2009; 10:116-25.
27. Nakaya HI, Wrammert J, Lee EK, et al. Systems biology of vaccination for seasonal influenza in humans. Nat Immunol. 2011; 12:786-95.
28. Obermoser G, Presnell S, Domico K, et al. Systems scale interactive exploration reveals quantitative and qualitative differences in response to influenza and pneumococcal vaccines. Immunity. 2013; 38:831-44.
29. Bucasas KL, Franco LM, Shaw CA, et al. Early Patterns of Gene Expression Correlate With the Humoral Immune Response to Influenza Vaccination in Humans. J Infect Dis. 2011; 203:921-9.
30. Scherer CA, Magness CL, Steiger KV, et al. Distinct gene expression profiles in peripheral blood mononuclear cells from patients infected with vaccinia virus, yellow fever 17D virus, or upper respiratory infections. Vaccine. 2007; 25:6458-73.
31. Vahey MT, Wang Z, Kester KE, et al. Expression of genes associated with immunoproteasome processing of major histocompatibility complex peptides is indicative of protection with adjuvanted RTS,S malaria vaccine. J Infect Dis. 2010; 201:580-9.
32. Fuller CL, Brittingham KC, Porter MW, et al. Transcriptome analysis of human immune responses following live vaccine strain (LVS) Francisella tularensis vaccination. Mol Immunol. 2007; 44:3173-84.
33. Mosca F, Tritto E, Muzzi A, et al. Molecular and cellular signatures of human vaccine adjuvants. Proc Natl Acad Sci USA. 2008; 105: 10501-6.
34. Caproni E, Tritto E, Cortese M, et al. MF59 and Pam3CSK4 boost adaptive responses to influenza subunit vaccine through an IFN type Iindependent mechanism of action. J Immunol. 2012; 188:3088-98.
35. Korsholm KS, Petersen RV, Agger EM, Andersen P. T-helper 1 and Thelper 2 adjuvants induce distinct differences in the magnitude, quality and kinetics of the early inflammatory response at the site of injection. Immunology. 2010; 129:75-86.
36. Li D, Lewinger JP, Gauderman WJ, Murcray CE, Conti D. Using extreme phenotype sampling to identify the rare causal variants of quantitative traits in association studies. Genet Epidemiol. 2011; 35: 790-9.
37. Abecasis GR, Auton A, Brooks LD, et al. An integrated map of genetic variation from 1,092 human genomes. Nature. 2012; 491: 56-65.
38. Kong A, Steinthorsdottir V, Masson G, et al. Parental origin of sequence variants associated with complex diseases. Nature. 2009; 462: 868-74.
39. Debey S, Schoenbeck U, Hellmich M, et al. Comparison of different isolation techniques prior gene expression profiling of blood derived cells: impact on physiological responses, on overall expression and the role of different cell types. Pharmacogenomics J. 2004; 4:193-207.
40. Dinu I, Potter JD, Mueller T, et al. Gene-set analysis and reduction. Brief Bioinform. 2009; 10:24-34.